“Way out there” paper claiming to merge physics and biology retracted

A German professor who claims to have developed “a self-consistent field theory which is used to derive at all known interactions of the potential vortex” will have at least two papers retracted, thanks to the scrutiny of a concerned economist.

The first retraction has already appeared, in DNA and Cell Biology, for a paper by Konstantin Meyl called “DNA and Cell Resonance: Magnetic Waves Enable Cell Communication.” The notice says nothing:

Facebook study retracted after authors request substantial changes

The journal Cyberpsychology, Behavior, and Social Networking is retracting a paper about Facebook.

“Bridging the Gap on Facebook: Assessing Intergroup Contact and Its Effects for Intergroup Relations,” is by Sandy Schumann of the Free University of Brussels. The notice says only:

This article has been officially retracted from the Journal.

We asked journal editor Brenda K. Wiederhold for more information about the retraction, and she responded:

Scientists retract paper because they’re “not satisfied with the quality of some of the data”

A group of smoking researchers — no, not scientists who are on fire; scientists who study the effects of tobacco smoke — has retracted a 2009 article after deciding that they were no longer “satisfied with the quality of the data.”

The paper, “Cigarette Smoke–induced Oxidative/Nitrosative Stress Impairs VEGF- and Fluid Shear Stress–Mediated Signaling in Endothelial Cells,” came from the lab of Irfan Rahman, a lung disease expert at the University of Rochester. It appeared online in 2009 in Antioxidants & Redox Signaling, which will be familiar to readers watching the case of Dipak Das. 

As the notice explains:

Stem cell retraction leaves grad student in limbo, reveals tangled web of industry-academic ties

A contested retraction in Stem Cells and Development has left the Queensland University of Technology (QUT) graduate student who fought for it in limbo, uncertain if he will earn his PhD. And many of those who didn’t want the paper retracted have a significant financial interest in a company whose work was promoted by the research — despite any lack of disclosure in the now-retracted paper.

Here’s the notice:

Correction for MD Anderson’s Bharat Aggarwal arches eyebrows for the right reasons

We’ve written about mega-corrections that allow scientists to retrace virtually all of their steps yet preserve their publications as supposedly legitimate. And we’ve seen plenty of corrections that allow authors to assert that their conclusions are correct when evidently important pieces of data are themselves unreliable.

Now comes a correction that seems to us to strike the right chords, given the fact that editors are to a large extent at the mercy of authors in these situations.

Reverse tissue engineering: data reuse causes retractions of three papers from German organ researchers

The body count has reached three for a group of German tissue engineers who appear to have cloned their data in many of their publications.

Tissue Engineering Part A has retracted one of the papers from the investigators, titled “Clinically established hemostatic scaffold (tissue fleece) as biomatrix in tissue- and organ-engineering research,” which was published in 2003.

The notice states:

Korean stem cell investigation expands to another researcher, and more papers

Last month, we brought you the story of Soo-Kyung Kang, a Seoul National University stem cell researcher who has now retracted four papers amidst questions about image manipulation in a total of 14 studies. That story has drawn a great deal of attention in Korea, with comparisons to the Woo-Suk Hwang scandal, and has even led to a profile of Retraction Watch in the Seoul Daily, one of Korea’s largest newspapers.

We’ve now learned that the investigation has grown to 25 papers after an anonymous whistleblower warned about possible data fabrications in another paper by Kang, an associate professor of veterinary biotechnology, and Kyung-Sun Kang, director of the Adult Stem Cell Research Center in the same department (but no relation). And Soo-Kyung Kang was investigated in 2010, according to the Korea Herald.

The researchers’ labs are also under lockdown

Whistleblower forces retractions of four stem cell papers amid questions about more than a dozen studies

In a case that is a good reminder of why journal editors shouldn’t ignore anonymous tips, a Seoul National University stem cell researcher has been forced to retract four papers, and withdraw another under peer review, in Antioxidants & Redox Signaling following a whistleblower’s exhaustive analysis.

Two retractions by Soo Kyung Kang, a professor of veterinary biotechnology at Seoul National University, appeared on May 9 after an anonymous whistleblower sent a 70-slide PowerPoint presentation to the editors of ten journals that contained evidence of suspicious floating error bars, errors larger than actual measurements, pasted-together lanes in PCR gels and RNA and CHIP blots and several cases where the same control blot data is shown across different experiments and in different papers. In all, the whistleblower raises questions about 14 papers in the ten journals.

Here is the May 9 notice for “Nuclear Ago2/HSP60 contributes to broad spectrum of hATSCs function via Oct4 regulation”:

Will a new literature format “radically alter” how scientists write, review, and read papers?

A group of authors at a Pittsburgh company have proposed a new way to write, review, and read scientific papers that they claim will “radically alter the creation and use of credible knowledge for the benefit of society.”

From the abstract of a paper appearing in the new Mary Liebert journal Disruptive Science and Technology, which, according to a press release, will “publish out-of-the-box concepts that will improve the way we live”:

Redox, redux: Journal pulls paper over data problems

Antioxidants & Redox Signalling has issued much more detailed retraction notice for a paper it pulled last year that was marred by duplicate data.

As we reported then, the journal’s initial notice for the 2011 article, titled “Inhibition of LXRa-dependent steatosis and oxidative injury by liquiritigenin, a licorice flavonoid, as mediated with Nrf2 activation,” was underwhelming:

THIS WORK HAS BEEN RETRACTED BY THE AUTHORS

Although we learned at the time that a reader, Paul Brookes, of the University of Rochester, had raised concerns about the article to the editors of ARS and other publications, we were glad to see that ARS has decided to make a clean breast of matters. The study has been cited by other papers three times, according to Thomson Scientific’s Web of Knowledge.

Here’s the notice, from editor Chandan K. Sen: